欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Tazifylline HCl_79712-53-1_产品详情
79712-53-1
  • names:

    7-(2-hydroxy-3-(4-(3-(phenylthio)propyl)piperazin-1-yl)propyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione dihydrochloride

  • CAS号:

    79712-53-1

    MDL Number:
  • MF(分子式): C23H34Cl2N6O3S MW(分子量): 545.52
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Tazifylline HCl
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名 7-(2-hydroxy-3-(4-(3-(phenylthio)propyl)piperazin-1-yl)propyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione dihydrochloride
英文别名 Tazifylline hydrochloride; Tazifylline HCl; LN 2974; RS-49014; RS 49014; RS49014; LN2974; LN-2974;
CAS号 79712-53-1
Inchi InChI=1S/C23H32N6O3S.2ClH/c1-25-21-20(22(31)26(2)23(25)32)29(17-24-21)16-18(30)15-28-12-10-27(11-13-28)9-6-14-33-19-7-4-3-5-8-19;;/h3-5,7-8,17-18,30H,6,9-16H2,1-2H3;2*1H
InchiKey HFYFNZKRWQJSLF-UHFFFAOYSA-N
分子式 Formula C23H34Cl2N6O3S
分子量 Molecular Weight 545.52
溶解度Solubility
性状 Solid powder
储藏条件 Storage conditions Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).
产品说明 Tazifylline HCl(CAS:79712-53-1):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。
IntroductionTazifylline HCl is an antihistaminic agent.
Application1
Application2
Application3
警示图
危险性 Warning
危险性警示
安全声明
安全防护
备注
[1]Poizot A, Dumez D, Ferrandon P, Lefournier C, Michel A, Armstrong JM. Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline. Arzneimittelforschung. 1986 Apr;36(4):695-702. PubMed PMID: 2424463.
[2]Ring J, Galosi A, Harlow BJ, Reuter CA, Bieber T, Ruzicka T, Yee KF. Antiallergic effects of the new histamine H1-receptor antagonist tazifylline in healthy atopic and non-atopic subjects. Arzneimittelforschung. 1988 Feb;38(2):308-11. PubMed PMID: 2897197.
[3] Bruno R, Jullien I, Auger J, Iliadis A, Dow R, McEwen J, Cano JP, Pinhas H. Multiple-dose pharmacokinetics of the new H1-receptor antagonist tazifylline in healthy volunteers. Biopharm Drug Dispos. 1989 Jan-Feb;10(1):115-9. PubMed PMID: 2564283.
[4] Kiviranta K, Stenius-Aarniala B, Reuter C, Harlow B, Scott J. The reducing effects of tazifylline on histamine-induced bronchoconstriction in atopic asthmatics. Methods Find Exp Clin Pharmacol. 1989 Feb;11(2):119-21. PubMed PMID: 2565416.
[5] Nicholson AN, Stone BM. Antihistamines: impaired performance and the tendency to sleep. Eur J Clin Pharmacol. 1986;30(1):27-32. PubMed PMID: 3086105.
6: Savin JA, Dow R, Harlow BJ, Massey H, Yee KF. The effect of a new non-sedative H1-receptor antagonist (LN2974) on the itching and scratching of patients with atopic eczema. Clin Exp Dermatol. 1986 Nov;11(6):600-2. PubMed PMID: 2889550.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents